178871-22-2

Upstream product

• 178871-18-6 6-(2-Benzoyloxy-1-hydroxy-1-methyl-ethyl)-3-[4-(4-chloro-benzenesulfonylamino)-butyl]-azulene-1-carboxylic acid methyl ester 
• 178871-17-5 6-(1-Benzoyloxymethyl-vinyl)-3-[4-(4-chloro-benzenesulfonylamino)-butyl]-azulene-1-carboxylic acid methyl ester 
• 178871-08-4 3-[4-(4-Chloro-benzenesulfonylamino)-butyl]-6-(1,2-dihydroxy-1-methyl-ethyl)-azulene-1-carboxylic acid methyl ester 
• 178870-61-6 3-[4-(4-Chloro-benzenesulfonylamino)-butyl]-6-(1-hydroxy-1-methyl-ethyl)-azulene-1-carboxylic acid methyl ester 
• 178870-67-2 3-[4-(4-Chloro-benzenesulfonylamino)-butyl]-6-isopropenyl-azulene-1-carboxylic acid methyl ester 
• 178871-19-7 3-[4-(4-Chloro-benzenesulfonylamino)-butyl]-6-(2-hydroxy-1-hydroxymethyl-ethyl)-azulene-1-carboxylic acid methyl ester 

Downstream Products

• 178871-23-3 N-(4-{6-[2-(tert-Butyl-dimethyl-silanyloxy)-1-(tert-butyl-dimethyl-silanyloxymethyl)-ethyl]-azulen-1-yl}-butyl)-4-chloro-benzenesulfonamide 

Relevant academic research and scientific papers

Azulene derivatives as TXA2/PGH2 receptor antagonists - II. Synthesis and biological activity of 6-mono- and 6-dihydroxylated-isopropylazulenes

In order to examine the correlation between activity and hydrophilicity of the side chain of sodium 3-[4-(4-chlorobenzenesulfonylamino)butyl]-6- isopropylazulene-1-sulfonate (KT2-962), a non-prostanoid TXA2/PGH2 receptor antagonist,